FNDC3A Inhibitors primarily pivot around the modulation of various cellular signaling pathways and dynamics that encompass cellular adhesion, motility, and communication. Given that FNDC3A is embedded within these intricate cellular processes, altering these pathways can influence its functional outcomes. Agents like LY294002 and Wortmannin, by attenuating the PI3K/Akt pathway, can potentially sway the balance of cellular signaling. This is pivotal, as FNDC3A is surmised to partake in such signaling cascades, emphasizing the relevance of these inhibitors.
Furthermore, cellular adhesion, a critical process in which FNDC3A is believed to partake, can be influenced by agents like Y-27632, Blebbistatin, and NSC23766. By affecting the mechanics and dynamics of cell adhesion, these agents inevitably mold the terrain in which FNDC3A operates. The encompassing approach of these molecules, from direct pathway inhibition like PD98059's effect on MAPK/ERK to more overarching effects like BAPTA-AM's calcium chelation, offers a method to influence FNDC3A's role in the cellular environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that suppresses PI3K/Akt signaling. FNDC3A, being involved in cellular communication, can be influenced when this pathway is dampened. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that suppresses the MAPK/ERK pathway. Since FNDC3A has potential roles in signal transduction, this can indirectly impact its function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, affecting cell adhesion dynamics. Given FNDC3A's role in cellular adhesion, this can influence its interaction dynamics. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor. By modulating kinase activities related to cellular communication, it can indirectly affect FNDC3A function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor similar to LY294002. Suppressing the PI3K/Akt pathway might impact FNDC3A's role in cellular communication. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that suppresses JNK signaling. FNDC3A's potential role in signal transduction can be influenced by altering this pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator, influencing intracellular calcium levels. Given calcium's role in cellular signaling, this can indirectly affect FNDC3A function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. By modulating the p38 MAPK signaling pathway, it can indirectly modulate functions related to FNDC3A. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibitor of non-muscle myosin II, influencing cellular contraction and morphology, potentially affecting FNDC3A's role in cellular adhesion. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Rac1 inhibitor, impacting cell adhesion and motility dynamics. This might influence the roles FNDC3A plays in these processes. | ||||||